A consensus statement for safety monitoring guidelines of treatments for major depressive disorder
Autor: | Darryl Bassett, Michael Theodoros, John Tiller, Isaac Schweitzer, Philip B. Mitchell, Christopher G. Davey, M. Udina, Bill Lyndon, Carolyn Doughty, Gordon Parker, Michael Berk, Ian B. Hickie, Francesco Giorlando, Steven Moylan, Ajeet B. Singh, Jon Paul Khoo, Seetal Dodd, Gin S Malhi, Paul B. Fitzgerald |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2011 |
Předmět: |
medicine.medical_specialty
Depressive Disorder Major Consensus business.industry Health Status Alternative medicine MEDLINE General Medicine medicine.disease Mental health Antidepressive Agents Psychiatry and Mental health Patient safety Treatment Outcome medicine Major depressive disorder Humans Patient Safety Adverse effect Intensive care medicine Psychiatry business Depression (differential diagnoses) Safety monitoring Research Article |
Zdroj: | The Australian and New Zealand Journal of Psychiatry |
ISSN: | 1440-1614 0004-8674 |
Popis: | Objective: This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring. Method: Data were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content. Results: Screening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment. Conclusion: The adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression. |
Databáze: | OpenAIRE |
Externí odkaz: |